Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 5

Results For "RI"

10747 News Found

Experts calls for urgent preventive action as hypertension cases rise
Healthcare | May 18, 2026

Experts calls for urgent preventive action as hypertension cases rise

Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare


Surya Hospitals expands advanced women-centric health services
Hospitals | May 18, 2026

Surya Hospitals expands advanced women-centric health services

New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai


Dr. Reddy’s launches generic semaglutide in Canada
News | May 16, 2026

Dr. Reddy’s launches generic semaglutide in Canada

Dr. Reddy’s is the first company to receive Health Canada approval for generic Semaglutide Injection in Canada


Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority
Drug Approval | May 15, 2026

Indoco Remedies' Baddi plant gets EU GMP approval from Malta Medicines Authority

The certification follows an inspection conducted by the Malta Medicines Authority between January 29, 2026, and February 3, 2026


Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore
News | May 15, 2026

Senores Pharma reports 62% rise in FY26 total income to Rs. 664 crore

The company reported a 108% rise in profit after tax, driven by strong growth in regulated markets, branded generics, and U.S. expansion initiatives


Suven Life Sciences reaches 76% milestone in Phase 3 masupirdine trial for Alzheimer’s agitation
Clinical Trials | May 14, 2026

Suven Life Sciences reaches 76% milestone in Phase 3 masupirdine trial for Alzheimer’s agitation

The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies


Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy
News | May 13, 2026

Actio Biosciences launches Phase 1b/2 trial for ultra-rare pediatric epilepsy therapy

The company also confirmed that ABS-1230 has been accepted into the U.S. Food and Drug Administration’s Rare Disease Evidence Principles (RDEP) process


Mankind’s Rajeev Juneja contributes Rs. 9.17 crore to National Defence Fund
News | May 13, 2026

Mankind’s Rajeev Juneja contributes Rs. 9.17 crore to National Defence Fund

This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces


Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC
People | May 13, 2026

Brinton Pharma appoints Sathya Narayanan as CEO – India Cluster & JPAC

Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets